Dr. Othmar Pfannes, founder and CEO of Genedata, a bioinformatics company headquartered in Switzerland delivering enterprise software, data analysis consulting, and business-process analysis services to the life sciences community, reveals some insights into Genedata’s business strategy and how ultimately their mission is to contribute to reducing the costs of drug research and development.
Genedata seems like a company at the cutting-edge; transforming data into intelligence, with innovative software solutions. What was it that prompted you to found the company back in 1997?
The concept of our company is to focus on key R&D processes that are both highly complex and data-rich
